Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

2017 Forecast – Ophthalmic Drugs Global Market News, Industry Size, Share, Analysis and Research to 2022

Monday, March 20, 2017 2:39
% of readers think this story is Fact. Add your two cents.

(Before It's News)

New report on Ophthalmic Drugs are the drugs that are used for the treatment of eye diseases and disorders. The ophthalmic drugs market is growing due to increase in prevalence of eye disorders and the use of combination therapies. Combination therapies have various advantages over traditional medication such as improved patient compliance and efficacy.

The drivers that support the growth of ophthalmic drug market are aging population, changing lifestyle, technological changes, and increase in healthcare spending. Lack of awareness among people regarding eye diseases and disorders, absence of health insurance in developing countries are some of the challenges faced by the ophthalmic drugs market.Key players in the market focus on product launch, research & new product development, and mergers & acquisition. Product launch, with new combination therapies is the most important strategy adopted by major players in market. Novartis (ALCON), Allergan, Santen, Pfizer, Merck and Roche are the major players in the global ophthalmic drugs market. ALCON launched ILEVRO Suspension used to reduce pain and inflammation resulting from cataract surgery.

Get Free Sample Report Of Ophthalmic Drugs Market @ http://www.marketresearchstore.com/report/world-ophthalmic-drugs-market-opportunities-and-forecasts-68416#RequestSample

The market is segmented into Dry eye drugs, Retinal drugs, Anti-inflammatory/allergy/infective drugs, Anti-glaucoma drugs. Glaucoma has the largest market share in the ophthalmic drugs market.

Ophthalmic drug type market is segmented into Prescription drugs and OTC drugs. OTC drugs for ocular allergy and dry eye is rapidly growing.
Porter’s five forces model reveals that bargaining power of supplier is less due to low switching cost and bargaining power of buyers is high due to availability of substitute products. Threat of substitute is high due to similarity in therapeutic functioning. Business strategies adopted by key players are analyzed. SWOT analysis helps in understanding the internal and external factors required for strategic business planning.

Do Inquiry To Buy Report Of Ophthalmic Drugs Market @ http://www.marketresearchstore.com/report/world-ophthalmic-drugs-market-opportunities-and-forecasts-68416#InquiryForBuying

MARKET BY TARGETED DRUGS

  • Dry eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/Allergy/Infective Drugs
  • Anti-Glaucoma Drugs

MARKET BY TYPE

  • Prescription Drugs
  • OTC Drugs

MARKET BY GEOGRAPHY

  • 1.North America
  • U.S.
  • 2.Europe
  • Germany
  • UK
  • France
  • 3.Asia Pacific
  • Japan
  • India
  • China
  • 4.LAMEA

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected] 
Web: http://www.marketresearchstore.com/

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.